CSIMarket
 


Seelos Therapeutics inc   (SEEL)
Other Ticker:  
 


Seelos Therapeutics Inc 's Net Cash Flow Margin by quarter

Trends, Rankings, Statistics



SEEL Net Cash Flow Margin (Dec 31 2023)
IV. Quarter
(Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
Y / Y Revenue Change 1562.5 % 1127.78 % 2105.26 % 3265.38 % 53.85 %
Seq. Revenue Change 50.45 % 5.49 % -52.11 % 2087.5 % 11.11 %
Revenue In Millions $0.67 $0.44 $0.42 $0.88 $0.04
Net Cash Flow Margin 61.95 % -737.33 % -1960.86 % -168.46 % -37445 %
Net Cash Flow Margin Total Ranking # 277 # # # #
Net Cash Flow In Millions $0.41 $-3.26 $-8.22 $-1.47 $-14.98
Y / Y Net Cash Flow Change - - - - -
Seq. Net Cash Flow Change - - - - -


Commenting fourth Quarter 2023 Net Cash Flow Margin
Company's Net Cash Flow Margin improved in IV. Quarter to 61.95 %, a new company low.

Observing fourth quarter 2023 results within Major Pharmaceutical Preparations industry 38 other companies have achieved higher Net Cash Flow Margin. While Net Cash Flow Margin overall ranking has deteriorated compare to previous quarter from to 277.

SEEL's Net Cash Flow Margin fourth quarter 2023 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 39
Healthcare Sector # 72
Overall # 276

Net Cash Flow Margin Statistics
High Average Low
167286.21 % 46949.42 % 61.95 %
(Jun 30 2021)   (Dec 31 2023)




Other Net Cash Flow Margin Profitability Ratios
SEEL's Cumulative Net Cash Flow Margin
Major Pharmaceutical Preparations Industry Net Cash Flow Margin Trends and Statistics
Healthcare Sector Net Cash Flow Margin Statistics
Net Cash Flow Margin Profitability Trends for overall market
SEEL's Net Cash Flow Margin Profitability versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Net Cash Flow Margin
Lowest Ranking Net Cash Flow Margin
Net Cash Flow Margin Profit Margin for SEEL's Competitors
Net Cash Flow Margin Profit Margin for Seelos Therapeutics Inc 's Suppliers
Net Cash Flow Margin Profit Margin for SEEL's Customers

You may also want to know
SEEL's Annual Growth Rates SEEL's Profitability Ratios SEEL's Asset Turnover Ratio SEEL's Dividend Growth
SEEL's Roe SEEL's Valuation Ratios SEEL's Financial Strength Ratios SEEL's Net Cash Flow Growth
SEEL's Roa SEEL's Inventory Turnover Ratio SEEL's Growth Rates SEEL's Dividend Comparisons


Companies with similar Net Cash Flow Margin in the quarter ending Dec 31 2023, within Major Pharmaceutical Preparations Industry Net Cash Flow MarginDec 31 2023 MRQ Net Cash FlowDec 31 2023 MRQ Revenue
Morphosys Ag  168.86 %$ 450.633 $ 266.872 
Liquidia Corporation  164.51 %$ 7.454 $ 4.531 
Ptc Therapeutics inc   139.67 %$ 428.874 $ 307.056 
Hookipa Pharma inc   129.65 %$ 9.603 $ 7.407 
Anaptysbio Inc   107.38 %$ 9.670 $ 9.005 
Macrogenics Inc   103.15 %$ 11.058 $ 10.720 
Nurix Therapeutics Inc   81.29 %$ 12.323 $ 15.159 
Alpine Immune Sciences Inc   80.88 %$ 24.954 $ 30.853 
Indivior Plc  70.81 %$ 774.000 $ 1,093.000 
Siga Technologies Inc  67.85 %$ 79.032 $ 116.481 
Seelos Therapeutics inc   61.95 %$ 0.412 $ 0.665 
Xeris Biopharma Holdings Inc   47.54 %$ 21.105 $ 44.390 
Capricor Therapeutics inc   47.24 %$ 5.710 $ 12.088 
Evolus Inc   39.60 %$ 24.153 $ 60.999 
Entrada Therapeutics Inc   37.56 %$ 15.720 $ 41.848 
Intra cellular Therapies Inc   36.61 %$ 48.365 $ 132.099 
Optinose Inc   34.43 %$ 6.840 $ 19.864 
Bristol myers Squibb Company  34.43 %$ 3,951.000 $ 11,477.000 
Theratechnologies Inc   29.18 %$ 23.856 $ 81.764 
Sanofi  27.42 %$ 14,264.320 $ 52,016.960 
Kamada Ltd   24.04 %$ 34.258 $ 142.519 
Teva Pharmaceutical Industries Limited  21.93 %$ 977.000 $ 4,456.000 
Ani Pharmaceuticals Inc  21.30 %$ 28.043 $ 131.654 
Blueprint Medicines Corporation  19.76 %$ 15.369 $ 77.776 
Corcept Therapeutics Inc  17.54 %$ 23.751 $ 135.405 
Organon and Co   17.46 %$ 279.000 $ 1,598.000 
Jazz Pharmaceuticals Plc  16.86 %$ 170.620 $ 1,011.935 
Regeneron Pharmaceuticals Inc   16.82 %$ 577.600 $ 3,434.300 
Beigene ltd   16.59 %$ 105.092 $ 633.489 
United Therapeutics Corporation  16.27 %$ 100.000 $ 614.700 




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com